最新公告:

  没有公告

您现在的位置: 心灵之窗-眼科医生网 >> 眼科常识 >> 第17届全国会 >> 正文
专题栏目
更多内容
相关文章
更多内容
A novel angiogenesis inhibitor HM-3 involvement in laser-induced choroidal neovascularization in mice           ★★★
A novel angiogenesis inhibitor HM-3 involvement in laser-induced choroidal neovascularization in mice
作者:袁冬青 文章来源:南京医科大学第一附属医院 点击数:379 更新时间:2012/9/13
Purpose: An RGD modified endostatin-derived synthetic peptide, named HM-3, is a polypeptide angiogenesis inhibitor previously synthesized in our laboratory. To evaluate the effect and mechanism of HM-3 on laser-induced choroidal neovascularization (CNV) in mice.
Methods: CNV was induced in both eyes of 50 C57BL/6-background mice using laser-induced rupture of Bruch's membrane. After retinal photocoagulation, those mice were randomly divided into 5 groups. Balanced salt solution (for control), HM-3 (10 mg/ml; 20 mg/ml and 40mg/ml) and bevacizumab (25 mg/ml) was administered intravitreally immediately after laser application for each eye (1 μl). Fundus fluorescein angiography (FFA) and fluorescein isothiocyanate (FITC) dextran were performed to observe the choroid vessels and to evaluate vessel leakage by fluorescence intensity at day 7 and 14. Immunohistochemistry and Western blot were used to detect vascular endothelial growth factor (VEGF), IL-6 and extracellular regulated protein kinases (ERK1/2).
Results: FFA and FITC-dextran verified that the mean CNV area was significantly reduced in the eyes with HM-3 (40mg/ml) injection by 47.3% compared with control mice (P<0.01). The reduction of the CNV area in the HM-3 group (10mg/ml, 20mg/ml) and bevacizumab group were 33.1%41.2% and 39.8%, respectively. Immunohistochemistry detected that VEGF, IL-6 and ERK1/2 mainly expressing in the new fibrovascular tissue. Western blot showed that VEGF and ERK1/2 was highly increased in tissue explants of retinal pigment epithelium (RPE) and choroid in control group. But for tissue explants of RPE and choroid with HM-3 and bevacizumab injection, both the expression of VEGF, IL-6 and ERK1/2 were inhibited.
Conclusions: HM-3 both inhibits newly forming CNV and regresses established CNV. Inhibiting of the inflammatory reaction and angiogenic ability via the ERK1/2 signal may be a useful therapeutic strategy for treating CNV associated with age-related macular degeneration.
会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿:
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2012
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备18030162号